Summaries & Associations of Study Results
TR-480 Lauric Acid Diethanolamine Condensate
Target Organs and Levels of Evidence
NTP Technical Report Number 480
Produced from Chemtrack Database 09/19/01
| CHEMICAL/ CAS NUMBER | PEER REVIEW DATE | PRIMARY USES | ROUTE/EXPOSURE LEVELS | STUDY LABORATORY |
|---|---|---|---|---|
| LAURIC ACID DIETHANOLAMINE CONDENSATE 120-40-1 |
12/10/97 | FOAM STABILIZER FOR LIQUID HOUSEHOLD DETERGENTS AND SHAMPOOS. (TDB) | Topical R: 0, 50, OR 100 MG/KG M: 0, 100, OR 200 MG/KG (50/SEX/SPECIES/GROUP) | Battelle Columbus Laboratory |
| LEVELS OF EVIDENCE OF CARCINOGENICITY--ORGAN/TISSUE (NEOPLASM): | ||||
| MR: NO EVIDENCE | ||||
| NON-NEOPLASTIC LESIONS: | SKIN: EPIDERMAL HYPERPLASIA; SEBACEOUS GLAND HYPERPLASIA; HYPERKERATOSIS; CHRONIC INFLAMMATION; PARAKERATOSIS | |||
| FR: NO EVIDENCE | ||||
| NON-NEOPLASTIC LESIONS: | SKIN: EPIDERMAL HYPERPLASIA; SEBACEOUS GLAND HYPERPLASIA; HYPERKERATOSIS; CHRONIC INFLAMMATION; PARAKERATOSIS | |||
| MM: NO EVIDENCE | ||||
| NON-NEOPLASTIC LESIONS: | SKIN: EPIDERMAL HYPERPLASIA; SEBACEOUS GLAND HYPERPLASIA; HYPERKERATOSIS; CHRONIC INFLAMMATION; PARAKERATOSIS | |||
| THYROID GLAND: FOLLICULAR CELL HYPERPLASIA | ||||
| FM: SOME EVIDENCE | LIVER: ADENOMA 23/50 32/49 29/50 ADENOMA OR CARCINOMA COMBINED 28/50 40/49 36/50 | |||
| NON-NEOPLASTIC LESIONS: | SKIN: EPIDERMAL HYPERPLASIA; SEBACEOUS GLAND HYPERPLASIA; HYPERKERATOSIS; CHRONIC INFLAMMATION; PARAKERATOSIS | |||
Web page last updated on February 10, 2006
